Trexquant Investment’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-25,469
| Closed | -$132K | – | 1913 |
|
|
2024
Q3 | $132K | Buy |
+25,469
| New | +$132K | ﹤0.01% | 1466 |
|
|
2024
Q2 | – | Sell |
-101,899
| Closed | -$501K | – | 1924 |
|
|
2024
Q1 | $501K | Buy |
101,899
+36,140
| +55% | +$178K | 0.01% | 1146 |
|
|
2023
Q4 | $578K | Buy |
+65,759
| New | +$578K | 0.01% | 1022 |
|
|
2023
Q2 | – | Sell |
-10,655
| Closed | -$343K | – | 1882 |
|
|
2023
Q1 | $343K | Sell |
10,655
-5,770
| -35% | -$186K | 0.01% | 1146 |
|
|
2022
Q4 | $303K | Buy |
+16,425
| New | +$303K | 0.01% | 1104 |
|
|
2022
Q2 | – | Sell |
-16,814
| Closed | -$328K | – | 1943 |
|
|
2022
Q1 | $328K | Buy |
+16,814
| New | +$328K | 0.02% | 962 |
|
|
2018
Q3 | – | Sell |
-14,499
| Closed | -$398K | – | 1244 |
|
|
2018
Q2 | $398K | Sell |
14,499
-7,688
| -35% | -$211K | 0.03% | 608 |
|
|
2018
Q1 | $683K | Buy |
22,187
+15,367
| +225% | +$473K | 0.05% | 532 |
|
|
2017
Q4 | $244K | Buy |
+6,820
| New | +$244K | 0.03% | 837 |
|
|
2017
Q3 | – | Sell |
-8,766
| Closed | -$231K | – | 1085 |
|
|
2017
Q2 | $231K | Buy |
+8,766
| New | +$231K | 0.06% | 602 |
|
|
2016
Q2 | – | Sell |
-48,002
| Closed | -$838K | – | 1151 |
|
|
2016
Q1 | $838K | Buy |
48,002
+22,902
| +91% | +$400K | 0.1% | 355 |
|
|
2015
Q4 | $857K | Sell |
25,100
-15,200
| -38% | -$519K | 0.08% | 454 |
|
|
2015
Q3 | $1.2M | Buy |
40,300
+10,400
| +35% | +$309K | 0.1% | 347 |
|
|
2015
Q2 | $956K | Sell |
29,900
-13,400
| -31% | -$428K | 0.11% | 346 |
|
|
2015
Q1 | $897K | Buy |
43,300
+25,500
| +143% | +$528K | 0.09% | 421 |
|
|
2014
Q4 | $301K | Buy |
+17,800
| New | +$301K | 0.05% | 689 |
|